Diagnosis neurological disease with

Sateia and Nowell [85] have proposed that long-term treatment with hypnotic medication could be implemented in patients with persistent insomnia not related to mental disorders, neurological diseases, medical conditions, or the effect of a substance of abuse or medication. In addition, nonpharmacological approaches have to be proven ineffective. Circumstances in which the long-term administration of hypnotic drugs must be discontinued include the development of tolerance and dose escalation, the occurrence of severe adverse events, and the diagnosis of newly developed disabilities. 

Sillevis-Smitt P, Manley G, Moll JW, Dalmau J, Posner JB. Pitfalls in the diagnosis of autoantibodies associated with paraneoplastic neurologic disease. Neurology 1996 46(6) 1739-1741. 

Landing, B. H., and J. H. Rubinstein Biopsy diagnosis of neurologic diseases in children, with emphasis on the lipidoses. In Cerebral Sphingolipidoses. Eds. S. M. Aronson and B. W. Volk, p. 1. New York Academic Press 1962. 

---